A Trademark

Trademark Overview

On Thursday, May 5, 2022, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 97396858. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, May 20, 2024. This trademark is owned by Editas Medicine, Inc.. The A trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services
a

General Information

Serial Number97396858
Word MarkA
Filing DateThursday, May 5, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Description of MarkThe mark consists of a red stylized "A" with alternate solid and shaded sides.
Indication of Colors claimedThe color(s) red is/are claimed as a feature of the mark.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 10, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEditas Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameEditas Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events

Event DateEvent Description
Monday, May 9, 2022NEW APPLICATION ENTERED
Tuesday, May 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Monday, July 25, 2022NON-FINAL ACTION WRITTEN
Monday, July 25, 2022NON-FINAL ACTION E-MAILED
Monday, July 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 17, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 17, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 17, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, August 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 20, 2023SOU EXTENSION 1 FILED
Thursday, April 20, 2023SOU EXTENSION 1 GRANTED
Saturday, April 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 28, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 28, 2023SOU EXTENSION 2 FILED
Saturday, October 28, 2023SOU EXTENSION 2 GRANTED
Tuesday, October 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2024SOU EXTENSION 3 GRANTED
Monday, May 20, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 20, 2024SOU EXTENSION 3 FILED
Tuesday, May 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

research others pharmaceutical development trials services clinical scientific namely conducting